Division of Nephrology and Hypertension, Oregon State University and Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code CR9-4, Portland, OR 97201, USA.
J Clin Pharmacol. 2012 Jan;52(1 Suppl):63S-71S. doi: 10.1177/0091270011420260.
Chronic kidney disease is a worldwide problem. Accurate assessment of kidney function is important for defining stages of kidney disease and assisting with drug dosing. Glomerular filtration rate (GFR) is a good index of the health of the kidney. Although measured GFR using an exogenous substance is the most accurate, it is difficult to obtain due to cost and resources. Equations calculating creatinine clearance and estimated GFR as a measure of kidney function have been developed using serum creatinine as a marker of kidney function. The Cockcroft-Gault, Modification of Diet in Renal Disease, and Chronic Kidney Disease Epidemiology Collaboration equations have been shown to have statistically significant differences in estimating GFR in various populations. Drug-dosing adjustments based on the various equations may differ. However, without clinical outcome data, it is yet to be determined whether these differences are clinically significant.
慢性肾脏病是一个全球性的问题。准确评估肾功能对于确定肾脏病的阶段和协助药物剂量调整非常重要。肾小球滤过率(GFR)是肾脏健康的一个很好的指标。虽然使用外源性物质测量 GFR 是最准确的,但由于成本和资源的原因,很难获得。已经开发了使用血清肌酐作为肾功能标志物来计算肌酐清除率和估计 GFR 的方程,以作为肾功能的衡量标准。已经表明,Cockcroft-Gault、肾脏病饮食改良和慢性肾脏病流行病学合作方程在各种人群中估计 GFR 时存在统计学上的显著差异。基于各种方程的药物剂量调整可能会有所不同。然而,在没有临床结果数据的情况下,尚不确定这些差异是否具有临床意义。